In early September 2022, it was announced that Amplion Inc had been acquired by Science and Medicine Group - a research and advisory firm out of Arlington, VA. Having a very limited SBIR Involvement, Amplion was indicated as a precision medicine intelligence platform using AI to support strategic decisioning for pharma and diagnostic developer, from drug research and discovery to companion diagnostic development through to patient care, Amplion personnel use biomarkers as key to delivering on the promise of personalized medicine. The firm offers two products, one paid for and one for free: BiomarkerBase⢠is the complete knowledge base and alert service for clinical biomarkers. Biomarker Trends⢠is the systematic analysis of key trends related to the development, regulation, and commercialization of biomarkers to include a free annual report summarizing annual trends for biomarker-based IVD tests. With propriety technology, BiomarkerEngine that curates public sources, BiomarkerBase⢠includes data about biomarkers in clinical use, aggregates and annotates that data, and provides access through a clean and intuitive interface. As the first and only database to include biomarkers in Laboratory-Developed Tests (LDTs), along with every biomarker in an FDA-approved test or drug label and thousands of biomarkers in clinical trials, BiomarkerBase⢠gives you an unprecedented view of the clinical biomarker lan
